 Screeningbaseline assessments will performed prior to the first treatment within approximately four weeks of the treatment and will include a detailed medical history and physical examination,standard of Care Laboratory tests CBC, CMP, tumor markers: as indicated: CEA and CA19-9; and coagulation baseline and as clinically indicated: INR, PTT, PT. Imaging to confirm respectability would include a high quality tri-phasic CT scan with 0.7mm cuts or Dynamic MRI with contrast to confirm the absence of metastatic disease Study specific tests include pre-treatment and post treatment Office visit pre-anesthesia visit, Morning of surgery, postop day 5 